Alison Jane Birtle

10PUBLICATIONS
82CO-AUTHORS
PharmacogenomicsPsychophysiologyPredictive and prognostic markersRadiation therapyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 01, 2024
Early Identification and Management of Patients with Rash on Apalutamide.

Alison J Birtle, Luigi Formisano, Vincent Descamps

|Jun 24, 2024
Reply to P. de Boissieu et al.

Alison Birtle, Robert Jones, Fay H Cafferty

|Feb 13, 2024
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial.

Alison Jane Birtle, Robert Jones, John Chester

|Jul 21, 2023
Bladder-Sparing Treatment With Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients With Clinically Node-Positive Nonmetastatic Bladder Cancer.

Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan

|Aug 12, 2022
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.

Simon J Crabb, Syed Hussain, Eileen Soulis

|Jul 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.

Nicholas D James, Fiona C Ingleby, Noel W Clarke

Pageof 2